Text and Fitbit monitoring during isatuximab treatment
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This trial follows people with multiple myeloma who are getting isatuximab through a vein (IV). It tests how well real-world health tracking (text/app messages and Fitbit data) works during treatment, and whether it can help care teams understand your experience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have multiple myeloma that has come back or did not respond (relapsed/refractory), and isatuximab is an option for you
- You plan to receive isatuximab through a vein (IV), not as an injection under the skin
- You can and agree to use a smartphone (or similar device) to get and send messages or use a mobile app
- You’re willing to wear a Fitbit and allow the study to collect activity data
- Your health/ability to be active is limited but not too much (ECOG 0–2)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses your self-reported symptoms (PRO) and wearable/device data to help improve care for people with relapsed multiple myeloma who are starting new treatment. It may help by providing insights about how you’re doing during therapy—without changing your cancer treatment in a study-specific way.
This study tests whether remote monitoring and health coaching can improve quality of life in older adults with multiple myeloma who are experiencing fatigue. You'll use a tablet or smartphone to track symptoms and get support from a coach.
This trial tests a combination of four drugs—isatuximab, bortezomib, lenalidomide, and dexamethasone—for people with newly diagnosed multiple myeloma who cannot have a stem cell transplant. The goal is to see if adding isatuximab helps control the cancer better.
This trial studies a peer-based (partner) approach using text messages and a Fitbit app to help inactive women increase their physical activity. It may help you find easier, ongoing motivation and support to reach recommended activity levels.
This study tests whether using a wearable activity tracker can help reduce hospitalizations in people undergoing radiation therapy for cancer. Participants will wear a tracker to monitor their activity levels during treatment.
This study will test if a smartphone program and social media group can help Hispanic/Latino teens and young adults who had childhood cancer become more physically active. You would wear a Fitbit and use a phone app with culturally tailored tips and support.
Hear when a new Multiple myeloma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.